I. Introduction
Angiomyofibroblastoma is a rare benign mesenchymal tumor usually occurring in the vulvovaginal area of middle aged women 1. Fletcher and colleagues first described angiomyofibroblastoma in 1992. The importance of this rare neoplasm is related to its potential mimicry of more infiltrative and prognostically less favourable lesions such as aggressive angiomyxomas 2 . Aggressive angiomyxoma is a more infiltrative neoplasm that has a high propensity for local recurrence in contrast to an angiomyofibroblastoma 3 .Angiomyofibroblastoma is known to have distinct clinicopathologic features as a non aggressive benign mesenchymal tumor. The histology of angiomyofibroblastoma is characterized by bland looking stromal cells and abundant small blood vesssels. 4 We report a case of angiomyofibroblastoma along with review of literature.
Case details
A 45 year old female patient came to the gynecological out patient clinic with a 03 month history of painless swelling in the right labia majora. Physical examination of the swelling revealed a soft to firm,mobile mass measuring approximately 08 cm in largest dimension. Clinically,labial cyst was the diagnosis. Laboratory data were unremarkable. On radiological imaging, a provisional diagnosis of ischiorectal angiomyxoma was made keeping in mind differential diagnosis of angiomyofibroblastoma and other mesenchymal tumors. The lesion was removed by simple excision. Grossly,the lesion was well circumscribed measuring 9cm in the greatest dimension. Cut surface was gray white with occasional areas of myxoid appearance. Histologically, tumor showed alternating hypocellular and hypercellular areas comprising of many small to medium sized blood vessels. Blood vessels were predominantly thin walled capillary type. Occasionally very few blood vessels were of large size and showed thick hyalinized walls. Stroma consisted of plump spindle and ovoid cells scattered and occasionally forming aggregates around blood vessels. A few loose myxoid areas were present. No mucin was present. No cellular features of malignancy were present. No foci of hemorrhage was seen. Sparsely scattered adipocytes were seen within the stroma. Based on the above histological features,the diagnosis made was angiomyofibroblastoma of vulva.
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II. Discussion
Angiomyofibroblastoma is a rare mesenchymal tumor found in the vulva. It usually presents as a non tender vulval swelling 5 . Angiomyofibroblastoma occurs mainly,but not exclusively in the vulval region of premenopausal women 6 . Most cases of angiomyofibroblastoma measures less than 5 cm. In literature, the previously reported cases ranged from 0.5 cm to 13 cm in their greatest dimension 4 . Histologically, angiomyofibroblastoma is a well demarcated tumor and well vascularized with alternating hypocellular and hypercellular edematous areas composed of bland,plump,spindle or oval to spindle stromal cells,frequently aggregated around blood vessels 7 . Preoperative differential diagnosis includes bartholin gland cyst,labial cyst,inguinal hernia and mesenchymal tumors such as lipoma,angiomyofibroblastoma and aggressive angiomyxoma 4 . The diagnosis of angiomyofibroblastoma is complicated because of its shared histological features with other soft tissue tumors that can develop in female genital tract 4 . Within the vulva the chief differential diagnosis of angiomyofibroblastoma is likely to be aggressive angiomyxoma and cellular angiofibroma 6 . Angiomyofibroblastoma can be distinguished from aggressive angiomyxoma by its circumscribed borders,much higher cellularity,more numerous blood vessels with lack of vessel wall hyalinization,frequent presence of plump stromal cells,minimal stromal mucin and rarity of erythrocyte extravasation 8 . Angiomyofibroblastoma of the vulva is almost always a benign lesion which unlike aggressive angiomyxoma shows little or no tendency for local recurrence. However,a single case with sarcomatous transformation has been described 6 . Diagnostic confusion can also arise between angiomyofibroblastoma and cellular angiofibroma,both of which develop in the female genital tract and have prominent vascular components and bland stromal cells,although it is probably not of clinical significance 4 . In addition,both can have adipocytes or lipomatous component. The presence of round tumor cells clustered around blood vessels and a lack of numerous thick walled,hyalinized vessels and wispy collagen bundles helps distinguish angiomyofibrobllastoma from cellular angiofibroma.Immunohistochemistry do not distinguishes between angiomyofibroblastoma and aggressive angiomyxoma as immunohistochemistry profiles indicate a strong reactivity for vimentin with various expressions of desmin and alpha smooth muscle actin 4 . Angiomyofibroblastoma cases are desmin positive and alpha smooth muscle actin negative. However,some are negative for desmin or positive for alpha smooth muscle actin 6, 8, 9, 10 . The tumor cells are uniformly negative for cytokeratin and S-100 protein and CD34. Not all tumor cells are negative for alpha smooth muscle actin and CD34. Staining for ER and PR was observed in the nucleus of all tumor cells 1, 6, 8, 9, 10 . Bigotti et 11 al described about strong CD44 expression by aggressive angiomyxoma where as angiomyofibroblastoma shows a weak and heterogenous positivity for CD44. This might explain the more aggressive nature of aggressive angiomyxoma because this receptor is able to mediate migration of neoplastic cells on a hyaluronate rich extracellular matrix. It is speculated that the neoplastic cell of angiomyofibroblastoma and aggressive angiomyxoma of the vulva is a specific myofibroblast which probably arises from undifferentiated mesenchymal cells normally occurring in the lower female genital tract and both the tumors belong to a histopathological spectrum with overlapping features 11 . Angiomyofibroblastoma is a benign tumor and is generally non recurrent. Sincere efforts should be made to differentiate angiomyofibroblastoma from aggressive angiomyxoma which have a potential to metastasize and recur.
